Morena Fasano
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 9
- Cancer-related Molecular Pathways 7
- Colorectal Cancer Treatments and Studies 6
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies 10
-
- Lung Cancer Treatments and Mutations 9
- Pleural and Pulmonary Diseases 6
- Lung Cancer Diagnosis and Treatment 5
- Cancer Research top 10%
- Hepatology top 10%
-
- PI3K/AKT/mTOR signaling in cancer 5
- Co-authors
- Fortunato CiardielloFloriana MorgilloCarminia Maria Della CorteTeresa TroianiRaimondo Di LielloGiuseppe ViscardiErika MartinelliFederica Papaccio
- Journals
- SHILAP Revista de lepidopterología (4 papers)Clinical Cancer Research (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Morena Fasano
60 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 680
- Otorhinolaryngology 85
- Pulmonary and Respiratory Medicine 535
- Cancer Research 244
- Hepatology 80
Countries citing papers authored by Morena Fasano
This map shows the geographic impact of Morena Fasano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morena Fasano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morena Fasano more than expected).
Fields of papers citing papers by Morena Fasano
This network shows the impact of papers produced by Morena Fasano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morena Fasano. The network helps show where Morena Fasano may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Morena Fasano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 21 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 52 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 4 | |
| 11 | 2022 | 6 | |
| 12 | 2022 | 10 | |
| 13 | 2022 | 2 | |
| 14 | 2021 | 15 | |
| 15 | 2021 | 11 | |
| 16 | 2020 | 30 | |
| 17 | Mechanisms of resistance to EGFR-targeted drugs: lung cancerbreakdown → | 2016 | 351 |
| 18 | 2015 | 97 | |
| 19 | 2011 | 44 | |
| 20 | 2008 | 23 |
About Morena Fasano
Morena Fasano is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine, having authored 63 papers that have together received 1.4k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (10 papers), Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cancer-related Molecular Pathways (7 papers), Pleural and Pulmonary Diseases (6 papers), Colorectal Cancer Treatments and Studies (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Lung Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (680 citations), Otorhinolaryngology (85 citations) and Pulmonary and Respiratory Medicine (535 citations). Morena Fasano has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Fortunato Ciardiello, Floriana Morgillo, Carminia Maria Della Corte, Teresa Troiani, Raimondo Di Liello, Giuseppe Viscardi, Erika Martinelli, Federica Papaccio, Giovanni Vicidomini and Alfonso Fiorelli. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.